- Associate Professor
- Office: 244C
- Phone: 617.806.8514
- Email: email@example.com
- Mailing Address: 7 Greenhouse Road, Kingston, RI 02881
A major theme of Dr. Gören’s career in healthcare has been to ensure patients with serious mental illness are treated in the safest and most efficacious manner. She has worked with retrospective prescribing data to assess antipsychotic utilization and outcomes and developed and implemented quality improvement programs to improve the care of patients with serious mental illness. Dr. Gören maintains a clinical psychiatric practice on both inpatient and outpatient services.
Safe and effective use of psychotropics, particularly antipsychotics; drug interactions
B.S., Pharmacy, University of Rhode Island, 1993
Pharm.D., University of Rhode Island, 1997
Psychiatric Pharmacotherapy Residency, Albany College of Pharmacy 1998
Fellowship, Psychopharmacology, Albany College of Pharmacy 1999
Gören, JL, Beck, S, Shtasel, D, Mills, B, Dufresne, R. Development and delivery of a quality improvement program to reduce antipsychotic polytherapy. Am J Managed Care Pharm 16(6):393-401 (2011).
Gören, JL, Tewksbury, AT. The use of omega-3 fatty acids in mental illness. J Pharm Pract 24(5):452-471 (2011).
Gören, JL, Carlat, D. Drug interactions in psychiatry: a practical review. Carlat Psychiatry Report 9(2):1-3,5 (2011).
Gören, JL, Wiseman, C. Fact or fiction: Quetiapine is effective for anxiety. Curr Psychiatry, submitted
Gören, JL, Tewksbury, A. Drug interactions and polypharmacy. In Ritsner M. (ed). Psychiatric Polypharmacy Springer in press.